Search Within

David H Ilson

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (33)
  2. Gastrointestinal Oncology Service (33)
  3. Genitourinary Oncology Service (33)
  4. Solid Tumor Oncology Division (33)
  5. GSK Faculty (26)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Yelena Janjigian (28)
  2. David Solit (26)
  3. Geoffrey Ku (26)
  4. Nikolaus Schultz (21)
  5. Jaclyn Hechtman (19)
  6. David Kelsen (18)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (7)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (2)
  4. Cancer Discovery (2)
  5. Lancet Oncology (2)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (14)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (4)
  4. Elsevier Inc. (3)
  5. Elsevier Science, Inc. (2)
  6. Springer (2)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Journal Article

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Wu, A. J.; Jones, D. R.; more...
    Journal of Geriatric Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Meeting Abstract

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A. J.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Ilson, D. H.; Won, E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer
    Journal Article

    Ku, G. Y.; Kemel, Y.; Maron, S. B.; Chou, J. F.; Ravichandran, V.; Shameer, Z.; Maio, A.; Won, E. S.; Kelsen, D. P.; Ilson, D. H.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save